Delays and Disparities in Uptake of Effective Antiseizure Medications
Delays and Disparities in Uptake of Effective Antiseizure Medications https://pediatricsnationwide.org/wp-content/uploads/2026/09/AdobeStock_865253071-1024x562.jpeg 1024 562 Katie Brind'Amour, PhD, MS, CHES https://pediatricsnationwide.org/wp-content/uploads/2021/03/Katie-B-portrait.gifNational prescribing trends suggest many children may receive suboptimal epilepsy therapy. In the wake of landmark trials (SANAD II) firmly supporting the use of lamotrigine for focal and valproate for generalized epilepsy, neurologists at Nationwide Children’s expected these drugs would be increasingly prescribed. Instead, their analysis of nearly 150,000 children receiving their first antiseizure monotherapy…





